Smith & Nephew plc · LSE:SN.
Smith & Nephew — Smith+Nephew — Shareholder Meeting (April 2020)
21 slides from Smith & Nephew's shareholder meeting presentation, Apr 9, 2020
Slide 1: Shareholders Presentation for Audiocast
Shareholders Presentation for Audiocast 9 April 2020
Slide 2: Forward looking statements and non-IFRS measures
Forward looking statements and non-IFRS measures This document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading margins, market trends and our product pipeline are forward-looking statements. Phrases such
Slide 3: Roberto Quarta, Chair
Roberto Quarta Chair
Slide 4: Smith+Nephew Board and Company Secretary
Smith+Nephew Board and Company Secretary Roberto Quarta Roland Diggelmann Vinita Bali Erik Engstrom Virginia Bottomley Robin Freestone Rick Medlock Marc Owen Angie Risley Bob White Susan Swabey (from 1 May) Company Secretary
Slide 5: Anne-Francoise Nesmes to be appointed Chief Financial Officer
Anne-Francoise Nesmes to be appointed Chief Financial Officer CFO of Merlin Entertainments and Non- executive Director of Compass Group PLC. Previously CFO of Dechra Pharmaceuticals PLC and held senior roles at GSK Anne-Francoise will join by 3 August Graham Baker, CFO left Board today and will leav
Slide 6: 2019 performance
2019 performance Dividend Share Price 22 40 37.5 20 36.0 35.0 35 18 30.8 30.8 16 30 14 12 25 10 20 8 2015 2016 2017 2018 2019 Apr 15 Apr 16 Apr 17 Apr 18 Apr 19 Apr 20 Dividend (US ¢ per share) Dividend (Pence per share) Smith & Nephew FTSE 100
Slide 7: Roland Diggelmann, Chief Executive Officer
Roland Diggelmann Chief Executive Officer
Slide 8: 2019 - Smith+Nephew delivered on growth and margin targets
2019 - Smith+Nephew delivered on growth and margin targets Record revenue of $5,138 million, trading profit margin 22.8%(1) Franchise growth Margin Development 23.0% 22.9%* Global 4.4% 22.8% 22.8% 22.6% 22.4% Orthopaedics 4.0% 22.2% 22.0% 22.0% Sports Med & ENT 7.0% 21.8% Advanced Wound 21.6% 2.2% M
Slide 9: Investing in long-term drivers
Investing in long-term drivers Key product launches M&A 2019 2020 Orthopaedic Joint Reconstruction Business WEREWOLF FLOW 90 ◊ OR3O◊ Wand Dual Mobility LENS 4K Surgical PICO◊ 7Y Imaging System sNPWT
Slide 10: Life Unlimited Care Collaboration Courage
A purpose-driven culture, focusing on talent and engagement Life Unlimited Care Collaboration Courage A culture of empathy and A culture of teamwork, A culture of continuous learning, understanding for each other, based on mutual trust and respect innovation and accountability our customers and pati
Slide 11: COVID-19: our priorities and approach
COVID-19: our priorities and approach • Employee health and safety • Serving our customers and their patients • Maintaining business continuity
Slide 12: OxVent ventilators
OxVent ventilators • Collaboration with University of Oxford, King’s College London • Manufactured by Smith+Nephew in Hull
Slide 13: Business impact
Business impact • 2020 guidance withdrawn • First half performance is being negatively impacted o Q1 underlying revenue to decline -8% on prior year o Q2 and H1 trading margin substantially down on prior year • Cost control measures are underway • We have a strong balance sheet and good access to li
Slide 14: A strong business with excellent long-term prospects
A strong business with excellent long-term prospects • Attractive markets • Proven strategy • Unique portfolio • Strong team
Slide 15: Roberto Quarta, Chair
Roberto Quarta Chair
Slide 16: Resolutions 1-4: Ordinary resolutions
Resolutions 1-4: Ordinary resolutions As at 7 April 2020 at 2:00pm Resolution Votes For % Votes Against % Votes Withheld To receive the audited 1 685,141,328 99.98 128,444 0.02 7,674,991 accounts To approve the Directors’ 2 676,749,445 97.71 15,843,720 2.29 352,762 Remuneration Policy To approve the
Slide 17: Resolutions 5-13: Re-election of Directors
Resolutions 5-13: Re-election of Directors As at 7 April 2020 at 2:00pm Resolution Votes For % Votes Against % Votes Withheld 5 Graham Baker Resolution not put to meeting 6 Vinita Bali 591,473,788 94.09 37,131,758 5.91 64,323,577 Rt. Hon Baroness 7 690,708,099 99.72 1,917,540 0.28 301,887 Virginia B
Slide 18: Resolutions 14-17: Ordinary resolutions
Resolutions 14-17: Ordinary resolutions As at 7 April 2020 at 2:00pm Resolution Votes For % Votes Against % Votes Withheld 14 To re-appoint the Auditor 689,101,456 99.99 101,758 0.01 3,741,192 To authorise the Directors’ to determine 15 692,625,608 99.99 81,717 0.01 235,374 the remuneration of the A
Slide 19: Resolutions 18-21: Special resolutions
Resolutions 18-21: Special resolutions As at 7 April 2020 at 2:00pm Resolution Votes For % Votes Against % Votes Withheld To renew the Directors’ authority for the 18 682,047,234 98.46 10,643,771 1.54 254,025 disapplication of the pre-emption rights To authorise the Directors’ to disapply pre-emptio
Slide 20: Questions
Questions
Slide 21: Thank you for attending the Audiocast
Thank you for attending the Audiocast